Skeletal Healing

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition

Volumn , Issue , 2013, Pages 90-98

  Zuscik, Michael J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bone healing; Fracture healing; Molecular therapy; Skeletal healing; Therapeutic modalities

Indexed keywords

EID: 84908041803     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118453926.ch11     Document Type: Chapter

References (105)

1. Calori GM, Albisetti W, Agus A, Iori S, Tagliabue L. 2007. Risk factors contributing to fracture non-unions. Injury 38 (Suppl 2): S11-18.
2. Tzioupis C, Giannoudis PV. 2007. Prevalence of longbone non-unions. Injury 38 (Suppl 2): S3-9.
3. Garrison KR, Shemilt I, Donell S, Ryder JJ, Mugford M, Harvey I, Song F, Alt V. 2010. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev CD006950.
4. Einhorn TA. 1998. The cell and molecular biology of fracture healing. Clin Orthop 355 (Suppl): S7-21.
5. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. 2003. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation J Cell Biochem 88: 873-884.
6. Marsell R, Einhorn TA. 2011. The biology of fracture healing. Injury 42: 551-555.
7. Matsumoto T, Mifune Y, Kawamoto A, Kuroda R, Shoji T, Iwasaki H, Suzuki T, Oyamada A, Horii M, Yokoyama A, Nishimura H, Lee SY, Miwa M, Doita M, Kurosaka M, Asahara T. 2008. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol 215: 234-242.
8. Ueno M, Uchida K, Takaso M, Minehara H, Suto K, Takahira N, Steck R, Schuetz MA, Itoman M. 2011. Distribution of bone marrow-derived cells in the fracture callus during plate fixation in a green fluorescent proteinchimeric mouse model. Exp Anim 60: 455-462.
9. Henrotin Y. 2011. Muscle: A source of progenitor cells for bone fracture healing. BMC Medicine 9: 136.
10. Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ, Nanchahal J. 2011. TNF-alpha promotes fracture repair by augmenting the recruitment and differentia tion of muscle-derived stromal cells. Proc Natl Acad Sci U S A 108: 1585-1590.
11. Zhang X, Naik A, Xie C, Reynolds D, Palmer J, Lin A, Awad H, Guldberg R, Schwarz E, O ' Keefe R. 2005. Periosteal stem cells are essential for bone revitalization and repair. J Musculoskelet Neuronal Interact 5: 360-362.
12. Ushiku C, Adams DJ, Jiang X, Wang L, Rowe DW. 2010. Long bone fracture repair in mice harboring GFP reporters for cells within the osteoblastic lineage. J Orthop Res 28: 1338-1347.
13. Granero-Molto F, Weis JA, Miga MI, Landis B, Myers TJ, O ' Rear L, Longobardi L, Jansen ED, Mortlock DP, Spagnoli A. 2009. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27: 1887-1898.
14. Kitaori T, Ito H, Schwarz EM, Tsutsumi R, Yoshitomi H, Oishi S, Nakano M, Fujii N, Nagasawa T, Nakamura T. 2009. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60: 813-823.
15. Thompson Z, Miclau T, Hu D, Helms JA. 2002. A model for intramembranous ossification during fracture healing. J Orthop Res 20: 1091-1098.
16. Augustin G, Antabak A, Davila S. 2007. The periosteum Part 1: Anatomy, histology and molecular biology. Injury 38: 1115-1130.
17. Orwoll ES. 2003. Toward an expanded understanding of the role of the periosteum in skeletal health. J Bone Miner Res 18: 949-954.
18. Komatsu DE, Hadjiargyrou M. 2004. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone 34: 680-688.
19. Schipani E. 2005. Hypoxia and HIF-1 alpha in chondrogenesis. Semin Cell Dev Biol 16: 539-546.
20. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA. 2001. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16: 1004-1014.
21. Mountziaris PM, Mikos AG. 2008. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14: 179-186.
22. ZS Ai-Aql, AS Alagl, DT Graves, LC Gerstenfeld, TA Einhorn. 2008. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87: 107-118.
23. Gerstenfeld LC, Sacks DJ, Pelis M, Mason ZD, Graves DT, Barrero M, Ominsky MS, Kostenuik PJ, Morgan EF, Einhorn TA. 2009. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res 24: 196-208.
24. Uusitalo H, Salminen H, Vuorio E. 2001. Activation of chondrogenesis in response to injury in normal and transgenic mice with cartilage collagen mutations. Osteoarthritis Cartilage 9 (Suppl A): S174-S179.
25. Le AX, Miclau T, Hu D, Helms JA. 2001. Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Research 19: 78-84.
26. Murakami S, Noda M. 2000. Expression of Indian hedgehog during fracture healing in adult rat femora. Calcif Tissue Int 66: 272-276.
27. Pufe T, Wildemann B, Petersen W, Mentlein R, Raschke M, Schmidmaier G. 2002. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: A study in the rat. Cell Tissue Res 309: 387-392.
28. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med, 5: 623-628.
29. Athanasopoulos AN, Schneider D, Keiper T, Alt V, Pendurthi UR, Liegibel UM, Sommer U, Nawroth PP, Kasperk C, Chavakis T. 2007. Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J Biol Chem 282: 26746-26753.
30. Kawahata H, Kikkawa T, Higashibata Y, Sakuma T, Huening M, Sato M, Sugimoto M, Kuriyama K, Terai K, Kitamura Y, Nomura S. 2003. Enhanced expression of Runx2/PEBP2alphaA/CBFA1/AML3 during fracture healing. J Orthop Sci 8: 102-108.
31. Naik AA, Xie C, Zuscik MJ, Kingsley P, Schwarz EM, Awad H, Guldberg R, Drissi H, Puzas JE, Boyce B, Zhang X, O ' Keefe RJ. 2009. Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J Bone Miner Res 24: 251-264.
32. Lu H, Kraut D, Gerstenfeld LC, Graves DT. 2003. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology 144: 346-352.
33. Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V. 2006. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38: 1424-1429.
34. Betz OB, Betz VM, Nazarian A, Egermann M, Gerstenfeld LC, Einhorn TA, Vrahas MS, Bouxsein ML, Evans CH. 2007. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther 14: 1039-1044.
35. Vortkamp A, Pathi S, Peretti GM, Caruso EM, Zaleske DJ, Tabin C. 1998. Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech Dev 71: 65-76.
36. De Biase P, Capanna R. 2005. Clinical applications of BMPs. Injury 36 Suppl 3: S43-S46.
37. Kakar S, Einhorn TA, Vora S, Miara LJ, Hon G, Wigner NA, Toben D, Jacobsen KA, Al-Sebaei MO, Song M, Trackman PC, Morgan EF, Gerstenfeld LC, Barnes GL. 2007. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 22: 1903-1912.
38. Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei Q, Poon R, Alman BA. 2007. Beta-catenin signaling plays a disparate role in different phases of fracture repair: Implications for therapy to improve bone healing. PLoS Med 4: e249.
39. Huang Y, Zhang X, Du K, Yang F, Shi Y, Huang J, Tang T, Chen D, Dai K. 2012. Inhibition of beta-catenin signaling in chondrocytes induces delayed fracture healing in mice. J Orthop Res 30: 304-310.
40. Szczesny G. 2002. Molecular aspects of bone healing and remodeling. Pol J Pathol 53: 145-153.
41. Weiss S, Henle P, Bidlingmaier M, Moghaddam A, Kasten P, Zimmermann G. 2007. Systemic response of the GH/IGF-I axis in timely versus delayed fracture healing. Growth Horm IGF Res 18 (3): 205-12.
42. Lehmann W, Edgar CM, Wang K, Cho TJ, Barnes GL, Kakar S, Graves DT, Rueger JM, Gerstenfeld LC, Einhorn TA. 2005. Tumor necrosis factor alpha (TNFalpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 36: 300-310.
43. Baldik Y, Diwan AD, Appleyard RC, Fang ZM, Wang Y, Murrell GA. 2005. Deletion of iNOS gene impairs mouse fracture healing Bone 37: 32-36.
44. Kimble RB, Bain S, Pacifici R. 1997. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12: 935-941.
45. Gerstenfeld LC, Shapiro FD. 1996. Expression of bonespecific genes by hypertrophic chondrocytes: implication of the complex functions of the hypertrophic chondrocyte during endochondral bone development. J Cell Biochem 62: 1-9.
46. Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Pleshko CN, Bostrom MP. 2007. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41: 928-936.
47. Sudmann E, Hagen T. 1976. Indomethacin-induced delayed fracture healing. Arch Orthop Unfallchir 85: 151-154.
48. Ho ML, Chang JK, Wang GJ. 1998. Effects of ketorolac on bone repair: A radiographic study in modeled demineralized bone matrix grafted rabbits. Pharmacology 57: 148-159.
49. Vane JR. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232-235.
50. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O ' Keefe RJ. 2002. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109: 1405-1415.
51. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 99: 9656-9661.
52. Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater JJ, Carmouche J, Zhang X, Rubery PT, Rabinowitz J, Samulski RJ, Nakamura T, Soballe K, O ' Keefe RJ, Boyce BF, Schwarz EM. 2005. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 11: 291-297.
53. Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Löwik CW. 2002. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143: 1545-1553.
54. Skak SV, Jensen TT. 1988. Femoral shaft fracture in 265 children. Log-normal correlation with age of speed of healing. Acta Orthop Scand 59: 704-707.
55. Nieminen S, Nurmi M, Satokari K. 1981. Healing of femoral neck fractures; influence of fracture reduction and age. Ann Chir Gynaecol 70: 26-31.
56. Nilsson BE, Edwards P. 1969. Age and fracture healing: A statistical analysis of 418 cases of tibial shaft fractures. Geriatrics 24: 112-117.
57. Hee HT, Wong HP, Low YP, Myers L. 2001. Predictors of outcome of floating knee injuries in adults: 89 patients followed for 2-12 years. Acta Orthop Scand 72: 385-394.
58. Meyer RA Jr, Desai BR, Heiner DE, Fiechtl J, Porter S, Meyer MH. 2006. Young, adult, and old rats have similar changes in mRNA expression of many skeletal genes after fracture despite delayed healing with age. J Orthop Res 24: 1933-1944.
59. Meyer RA Jr, Meyer MH, Tenholder M, Wondracek S, Wasserman R, Garges P. 2003. Gene expression in older rats with delayed union of femoral fractures, J Bone Joint Surg Am 85-A: 1243-1254.
60. Bajada S, Marshall MJ, Wright KT, Richardson JB, Johnson WE. 2009. Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 secretion in human fracture non union stromal cells. Bone 45: 726-735.
61. Gruber R, Koch H, Doll BA, Tegtmeier F, Einhorn TA, Hollinger JO. 2006. Fracture healing in the elderly patient. Exp Gerontol 41: 1080-1093.
62. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H. 2004. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113: 846-855.
63. Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP. 2005. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Miner Res 20: 1659-1668.
64. Brandes RP, Fleming I, Busse R. 2005. Endothelial aging. Cardiovascular Research 66: 286-294.
65. Edelberg JM, Reed MJ. 2003. Aging and angiogenesis. Front Biosci 8: s1199-s1209.
66. Loder RT. 1988. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res 232: 210-216.
67. Blakytny R, Spraul M, Jude EB. 2011. Review: The diabetic bone: A cellular and molecular perspective. Int J Low Extrem Wounds 10: 16-32.
68. Beam HA, Parsons JR, Lin SS. 2002. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 20: 1210-1216.
69. Funk JR, Hale JE, Carmines D, Gooch HL, Hurwitz SR. 2000. Biomechanical evaluation of early fracture healing in normal and diabetic rats. J Orthop Res, 18: 126-132.
70. Alblowi J, Kayal RA, Siqueira M, McKenzie E, Krothapalli N, McLean J, Conn J, Nikolajczyk B, Einhorn TA, Gerstenfeld L, Graves DT. 2009. High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol 175: 1574-1585.
71. Kayal RA, Siqueira M, Alblowi J, McLean J, Krothapalli N, Faibish D, Einhorn TA, Gerstenfeld LC, Graves DT. 2010. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J Bone Miner Res 25: 1604-1615.
72. Hough S, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL. 1981. Correction of abnormal bone and mineral metabolism in chronic streptozotocininduced diabetes mellitus in the rat by insulin therapy. Endocrinology 108: 2228-2234.
73. Kayal RA, Alblowi J, McKenzie E, Krothapalli N, Silkman L, Gerstenfeld L, Einhorn TA, Graves DT. 2009. Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. Bone 44: 357-363.
74. Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC. 2003. A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 52: 1502-1510.
75. Gandhi A, Beam HA, O ' Connor JP, Parsons JR, Lin SS. 2005. The effects of local insulin delivery on diabetic fracture healing. Bone 37: 482-490.
76. Khazai NB, Beck GR Jr, Umpierrez GE. 2009. Diabetes and fractures: An overshadowed association. Curr Opin Endocrinol Diabetes Obes 16: 435-445.
77. Shamseddeen H, Getty JZ, Hamdallah IN, Ali MR. 2011. Epidemiology and economic impact of obesity and type 2 diabetes. Surg Clin North Am 91: 1163-1172, vii.
78. Schmitz MA, Finnegan M, Natarajan R, Champine J. 1999. Effect of smoking on tibial shaft fracture healing. Clin Orthop Relat Res 365: 184-200.
79. Sloan A, Hussain I, Maqsood M, Eremin O, El-Sheemy M. 2010. The effects of smoking on fracture healing. The Surgeon 8: 111-116.
80. Hadley MN, Reddy SV. 1997. Smoking and the human vertebral column: A review of the impact of cigarette use on vertebral bone metabolism and spinal fusion. Neurosurgery 41: 116-124.
81. Ueng SW, Lee MY, Li AF, Lin SS, Tai CL, Shih CH. 1997. Effect of intermittent cigarette smoke inhalation on tibial lengthening: Experimental study on rabbits. J Trauma 42: 231-238.
82. El-Zawawy HB, Gill CS, Wright RW, Sandell LJ. 2006. Smoking delays chondrogenesis in a mouse model of closed tibial fracture healing. J Orthop Res 24: 2150-2158.
83. Ma L, Zheng LW, Cheung LK. 2007. Inhibitory effect of nicotine on bone regeneration in mandibular distraction osteogenesis. Front Biosci 12: 3256-3262.
84. Silcox DH III, Daftari T, Boden SD, Schimandle JH, Hutton WC, Whitesides TE Jr. 1995. The effect of nicotine on spinal fusion. Spine 20: 1549-1553.
85. Silcox DH III, Boden SD, Schimandle JH, Johnson P, Whitesides TE, Hutton WC. 1998. Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract. Spine 23: 291-296.
86. Raikin SM, Landsman JC, Alexander VA, Froimson MI, Plaxton NA. 1998. Effect of nicotine on the rate and strength of long bone fracture healing. Clin Orthop Relat Res 353: 231-237.
87. Balatsouka D, Gotfredsen K, Lindh CH, Berglundh T. 2005. The impact of nicotine on osseointegration. An experimental study in the femur and tibia of rabbits. Clin Oral Implants Res 16: 389-395.
88. Balatsouka D, Gotfredsen K, Lindh CH, Berglundh T. 2005. The impact of nicotine on bone healing and osseointegration. Clin Oral Implants Res 16: 268-276.
89. Cesar-Neto JB, Duarte PM, Sallum EA, Barbieri D, Moreno H Jr, Nociti FH Jr. 2003. A comparative study on the effect of nicotine administration and cigarette smoke inhalation on bone healing around titanium implants. J Periodontol 74: 1454-1459.
90. Skott M, Andreassen TT, Ulrich-Vinther M, Chen X, Keyler DE, LeSage MG, Pentel PR, Bechtold JE, Soballe K. 2006. Tobacco extract but not nicotine impairs the mechanical strength of fracture healing in rats. J Orthop Res 24: 1472-1479.
91. Kung MH, Yukata K, O ' Keefe RJ, Zuscik MJ. 2011. Aryl hydrocarbon receptor-mediated impairment of chondrogenesis and fracture healing by cigarette smoke and benzo(a)pyrene. J Cell Physiol 227 (3): 1062-1070.
92. Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, Pollak AN, Golden JD, Valentin-Opran A. 2006. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88: 1431-1441.
93. Swiontkowski MF, Aro HT, Donell S, Esterhai JL, Goulet J, Jones A, Kregor PJ, Nordsletten L, Paiement G, Patel A. 2006. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 88: 1258-1265.
94. Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA. 2003. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 28: 1219-1224.
95. Garrison KR, Donell S, Ryder J, Shemilt I, Mugford M, Harvey I, Song F. 2007. Clinical effectiveness and costeffectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: A systematic review. Health Technol Assess 11: 1-iv.
96. FDA. 2003. Forteo approved for osteoporosis treatment. FDA Consum 37: 4.
97. Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, Garcia-Hernandez PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC. 2010. Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 25: 404-414.
98. Andreassen TT, Willick GE, Morley P, Whitfield JF. 2004. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif Tissue Int 74: 351-356.
99. Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak BH, Einhorn TA. 2005. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 87: 731-741.
100. Komatsubara S, Mori S, Mashiba T, Nonaka K, Seki A, Akiyama T, Miyamoto K, Cao Y, Manabe T, Norimatsu H. 2005. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 36: 678-687.
101. Kaback LA, Soung DY, Naik A, Geneau G, Schwarz EM, Rosier RN, O ' Keefe RJ, Drissi H. Teriparatide (1-34 human PTH) regulation of osterix during fracture repair. J Cell Biochem 105: 219-226.
102. Reynolds DG, Takahata M, Lerner AL, O ' Keefe RJ, Schwarz EM, Awad HA. 2011. Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model. Bone 48: 562-570.
103. Nakazawa T, Nakajima A, Shiomi K, Moriya H, Einhorn TA, Yamazaki M. 2005. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. Bone 37: 711-719.
104. Minear S, Leucht P, Jiang J, Liu B, Zeng A, Fuerer C, Nusse R, Helms JA. 2010. Wnt proteins promote bone regeneration. Sci Transl Med 2: 29ra30.
105. Einhorn TA. 2010. The Wnt signaling pathway as a potential target for therapies to enhance bone repair. Sci Transl Med 2: 42ps36.